Project Grant R56NS135053

Award Date 9/1/24
Completion Date 8/31/25
Dollars Obligated $677K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Novato, CA 94945, USA
Similar Awards
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $2,503,949 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Rockefeller University. The grant, awarded on May 1, 2025, supports a research project titled "Applying RNA Logic in Space and Time to Neurologic Disease". The project aims to develop new techniques and concepts to discover therapeutic targets for neurological diseases by studying...
This Project Grant award of $244,154, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research at the Albert Einstein College of Medicine to investigate the regulation of presynaptic gene transcripts during synaptogenesis. The research, conducted over the period from September 1, 2024 to June 30, 2027, will leverage the genetic accessibility and...
This Project Grant award, valued at $481,250.00 and provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to develop a synthetic biological system to manipulate subcellular RNAs and proteins in growth cones or synapses of subtype- and context-specific neurons. The goal is to enable unique forms of subcellular functional investigation in subtype- and...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $420,744 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Oregon Health & Science University (OHSU). The funding will support the development of a methodology to simultaneously analyze adenosine-to-inosine (A-to-I) RNA editing sites in targeted RNAs using long-read sequencing and characterize specific neuronal cell subtypes via short-read...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is focused on investigating the roles and mechanisms of epitranscriptomic regulation in the development and function of the mammalian nervous system. The $985,026 award, effective December 23, 2024 through November 30, 2032, supports three interrelated research projects: 1) examining the...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research dedicated to unraveling the regulatory mechanisms governing chromatin organization and gene transcription during neural development in the model organism Drosophila. The $127,145 award, effective May 1, 2025 through April 30, 2027, will fund a multi-faceted approach combining...
This federal Project Grant award of $364,448.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) focuses on investigating the neural functions of glycoprotein sialylation. The research aims to reveal sialylation-mediated mechanisms of glia-neuron coupling, elucidate the role of sialylation in promoting neuronal viability and resistance to oxidative stress, and characterize...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $404,340 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the University of Georgia Research Foundation, Inc. The project aims to develop a novel method using split fluorescent protein tags to map the localization of neurotransmitter receptors within neural circuits in the Drosophila model organism. This work will provide crucial new insights into the...
This Project Grant award of $270,434, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research by Princeton University to investigate the spatiotemporal regulation of mRNA and its role in neuronal remodeling during morphogenesis. The project will leverage Drosophila models to characterize the localization and motility of the chickadee (chic)...
This $195,896 Project Grant, awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to define the circuit connectivity between glioblastoma, a fatal brain cancer, and diverse neuronal populations in the mouse brain. The research aims to elucidate the role of cholinergic neuromodulatory inputs in regulating glioma progression, with the goal of...

The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $676,789 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program to the Buck Institute for Research on Aging. The grant supports research to investigate the in vivo impact of N6-methyladenosine (m6A), a common mRNA modification, on synaptic function and neurotransmitter release. The research aims to establish critical roles for the epitranscriptome in normal synaptic activity, provide comprehensive genomic data on m6A targets and regulatory mechanisms, and define new ways m6A intersects with other neuronal pathways. The project period is from September 1, 2024 to August 31, 2025.

As part of the project, the Buck Institute has issued a $122,674 sub-award to the Sloan-Kettering Institute for Cancer Research. The sub-recipient will be responsible for constructing and analyzing genomic datasets to elucidate the roles and functional impacts of the m6A regulatory pathway in the Drosophila nervous system, including m6A mapping, occupancy analysis, and transcriptome/translatome studies. They will also generate recombinant Drosophila strains to test cell-specific requirements and genetic dependencies for m6A regulation at the neuromuscular junction.

Generated 7/1/25, 3:52 AM